Hurum Co., Ltd. (KOSDAQ:353190)
South Korea · Delayed Price · Currency is KRW 2,165.00
+166.00 (8.30%)
At close: Oct 23, 2026
Hurum Revenue
Hurum had revenue of 21.96B KRW in the quarter ending June 30, 2026, a decrease of -8.22%. This brings the company's total for the last twelve months to 94.89B, down -1.67% year-over-year. In the year 2025, Hurum had annual revenue of 99.01B with 0.86% growth. That makes Hurum the 25,222nd largest company in the world by revenue and 1,479th in South Korea.
Revenue (ttm)
94.89B
Revenue Growth
-1.67%
P/S Ratio
0.18
Revenue / Employee
677.76M
Employees
140
Market Cap
17.05B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Hurum breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 99.01B | 845.62M | 0.86% |
| Dec 31, 2024 | 98.17B | 9.76B | 11.04% |
| Dec 31, 2023 | 88.41B | 21.50B | 32.13% |
| Dec 31, 2022 | 66.91B | -2.17B | -3.14% |
| Dec 31, 2021 | 69.08B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ChoA Pharmaceutical Co., LTD. | 61.16B |
| WooGene B&G | 56.49B |
| CXI Healthcare Technology Group | 51.45B |
| Seoul Pharma | 51.08B |
| Kwangdong Healthbio | 38.10B |
| Union Korea Pharm | 25.45B |
| Daesung Microbiological Labs. | 25.20B |
| BIFIDO | 14.63B |